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We analyzed the current status (as of the end of August 2008) of human mitochondrial genomes deposited in GenBank, amounting to
5140 complete or coding-region sequences, in order to present an overall picture of the diversity present in the mitochondrial DNA of
the global human population. To perform this task, we developed mtDNA-GeneSyn, a computer tool that identiﬁes and exhaustedly
classiﬁes the diversity present in large genetic data sets. The diversity observed in the 5140 human mitochondrial genomes was
compared with all possible transitions and transversions from the standard human mitochondrial reference genome. This comparison
showed that tRNA and rRNA secondary structures have a large effect in limiting the diversity of the human mitochondrial sequences,
whereas for the protein-coding genes there is a bias toward less variation at the second codon positions. The analysis of the observed
amino acid variations showed a tolerance of variations that convert between the amino acids V, I, A, M, and T. This deﬁnes a group
of amino acids with similar chemical properties that can interconvert by a single transition.Introduction
The recent increase in high-throughput DNA analysis
resulting from new automatic sequencing technologies
has had the side effect of condemning the public online
mitochondrial DNA (mtDNA) databases to quickly become
out of date. The depositing of complete human mtDNA
genomes in GenBank,1 to which authors are advised or
required to submit sequences prior to publication, is
increasing very fast since the ﬁrst worldwide mtDNA
population study appeared in the year 2000.2 One such
database is the highly consulted Mitomap database,3
whose lists of polymorphisms remain arguably the most
used references for clinical genetic publications. Typically,
authors perform an mtDNA screening in a case study
versus control group and conduct a search on Mitomap
for previous publications of any detected mutation in
order to infer novelty and any reported pathological effects
of listed mutations. It is difﬁcult (though not impossible)
to attribute a pathological effect to a polymorphism that
is reported in population surveys, especially those poly-
morphisms that are frequent in the population or recur-
rent in recent human evolution, so the population
frequency of a polymorphism is essential information for
inferring any negative phenotypic inﬂuence of that poly-
morphism. The fundamental role of Mitomap to the
mtDNA research community is indisputable, but prior to
a recent effort to keep its lists updated,3 (information
deposited is based on ~3000 coding region sequences),
many works have been published drawing conclusions
about the novelty of mtDNA polymorphisms based on
incomplete and outdated information. These biases poten-
tially affect several areas of clinical genetics, because628 The American Journal of Human Genetics 84, 628–640, May 15mtDNA variant associations have been tested in many
complex traits, such as longevity,4,5 Alzheimer (MIM
#104300),6 and male infertility,7 among many other traits.
Previous to the study reported here, the most informa-
tive database (in our opinion) for general mtDNA diversity
was mtDB—Human Mitochondrial Genome Database8—
which reports the mtDNA variation observed in 1865
complete sequences and 839 coding region sequences.
This database presents well the information for frequency,
location, and type of mutations observed (synonymous or
nonsynonymous, if protein coding). The information
deposited in this database can be joined to that presented
in Mitomap, and together with other online searching
queries, should constitute the standard steps conducted
by investigators for inferring the novelty of a mutation,
as suggested very recently.9
Lately, the same group responsible for Mitomap has
launched a new online tool, called Mitomaster.10 These
authors argue that simple catalogs, such as lists of patho-
genic mutations and haplogroup polymorphisms, are no
longer adequate, a position to which we are in agreement.
Static catalogs and lists are too quickly outdated in this age,
and researchers in this ﬁeld need the tools to access and use
the constantly updated data in centralized databases such
as GenBank. Studies based on the set of human mtDNA
sequences deposited in GenBank, instead of on the static
data reported in databases such as mtDB, will be using
a much larger set of sequences and will naturally have
better information on the population variation. In a fast-
moving ﬁeld, static databases such as mtDB rapidly
become outdated. The statement made above about
studies based on incomplete and outdated informa-
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just-published studies still refer to mtDB for information
on human mtDNA variability. Of course, this does not
mean that these studies are in any way invalid, but just
that these studies could be improved by using the full
amount of the sequence data currently available. In this
paper we provide the tools to do that.
It is very important to include information concerning
the frequencies observed in global populations (or local
populations if relevant) for any polymorphism as a normal
part of the evaluation of any potential pathological effect
of that polymorphism. Ruiz-Pesini et al.11 developed
a formula, which was implemented on Mitomaster, for
inferring the potential pathological effect of a polymor-
phism based on information including the frequency of
the polymorphism within the human population and
conservation at that site between species. Another obvious
parameter to be taken into consideration is the effect of
mutations in protein-coding genes—both Mitomaster
and the mtDB database present the synonymous or nonsy-
nonymous character of a given polymorphism. This
replaces the tedious process of manually consulting the
mitochondrial genetic code, the sequence of the revised
Cambridge Reference Sequence, to infer whether a position
is located in protein-coding genes, and a table with proper-
ties for the amino acids. However, the mtDB database
supplies this information listed by site and only for the
polymorphisms in a ﬁxed set of mtDNA sequences. Mito-
master currently gives this analysis only for a single
sequence at a time. It is becoming common for an investi-
gator to need to do this analysis for multiple sequences,
and for multiple sites within each sequence. Certainly
this is the case when the full set of mtDNA variations
within a population study needs to be characterized. The
synonymous or nonsynonymous classiﬁcation of varia-
tions within protein-coding genes and the comparison of
the site of variations to tRNA and rRNA secondary struc-
ture are critical information for inferring potential patho-
logical effects of a variation. Although Mitomaster does
supply this information, again it currently does so for
only a single sequence at a time. Mitomaster is also not
currently downloadable, so data conﬁdentiality cannot
be maintained with this particular analysis tool.
The primary aim of this study is to describe the level of
diversity observed in the current (as of the end of August
2008) set of human mitochondrial genomes deposited in
GenBank, a total of 5140 complete (or at least coding
section) sequences. The second aim is to provide a simple
downloadable software tool that can be used by others to
carry out this analysis themselves in the future as the
number of human mtDNA sequences continues to grow,
or to carry out the variation analysis on subpopulations of
particular interest. With this tool one does not need to be
restricted to the existing static online databases and can
independently checkvery largemtDNAsequencedatabases.
The software tool can be downloaded, to protect the conﬁ-
dentiality of any sequences analyzed with it. Finally, the
third aim is to compare the observed levels of diversity inThe Amthe current database of human mtDNA sequences with the
extreme limits of all possible transitions and transversions.
Material and Methods
The mtDNA-GeneSyn Computer Tool
for Sequence Analysis
ThemtDNA-GeneSyn tool for mitochondrial genome analysis was
developed for Windows-based platforms and implemented with
the Cþþ language. It is designed to have a simple and intuitive
graphical interface and the mtDNA-GeneSyn tool is freely avail-
able at the address listed in the Web Resources section. The tool
identiﬁes and classiﬁes the mtDNA polymorphisms present in
large data sets, with these functions organized in twomainmenus.
The menu ‘‘Polymorphisms’’ allows users to import a ﬁle in FASTA
format, containing sequences previously aligned versus a reference
sequence (which should be the ﬁrst sequence in the ﬁle). This
function identiﬁes the positions that are variable relative to the
reference, and the list of these variations can be exported as an
output ﬁle. This output ﬁle of the polymorphic positions can
also be exported to a binary input ﬁle recognized by the Network
software.12 Network analyses allow the reconstruction of mtDNA
phylogenies and the inference of haplogroup afﬁliations, and are
basically of two kinds: median-joining13 and reduced-median12
networks. When recurrence is expected, as in big data sets, the
reduced-median network is the indicated algorithm. But, as far as
we are aware, there was no easy and cost-free way of transforming
a big sequence data set into the binary input ﬁle necessary for this
analysis (DnaSP provides only DNAMultistate input format usable
inmedian-joining networks14). So, this functionwas implemented
in mtDNA-GeneSyn in order to facilitate the classiﬁcation of the
phylogeny, in cases where the user is using a personal data set.
The output ﬁle with the identiﬁed polymorphisms works as the
input ﬁle for the menu ‘‘Classiﬁcation.’’ The tool is not limited to
human mtDNA analyses, and can be applied to any mammalian
mtDNA studies, so the ﬁrst action when opening the ‘‘Classiﬁca-
tion’’ menu is to call again the reference sequence, in order to
obtain the information about the location of the 37 genes, control
region, and the reference sequence itself. The user can choose
between thedefaulthuman revisedCambridgeReference Sequence
(rCRS, accession number AC_00002115) or input anothermamma-
lian reference sequence in GenBank format (we advise the user to
use sequences curated inRefSeqdatabase16). Then the classiﬁcation
of the polymorphisms can be performed, either as a single position
or as entire data sets (completemtDNA sequences inmany individ-
uals, such as the total 5140 reported human mtDNA sequences).
Analyses of a data set of polymorphisms are partitioned into two
main groups, ‘‘protein positions’’ and ‘‘nonprotein positions,’’
and information provided by the tool for each is as exhaustible as
possible. Speciﬁcally for the ‘‘protein positions,’’ information con-
cerning the protein-coding gene, the type of substitution (synony-
mous/nonsynonymous), the codon before and after, the amino
acid and its properties (polarity and acidity) before and after, the
amino acid position inside the protein, and the frequency in the
database are provided. For the special cases of positions located in
overlapping genes/regions, these are counted twice, because they
interfere with the structure of the two genes or regions.
There are two other functions in mtDNA-GeneSyn for analyzing
a data set of polymorphisms, which are available only for human
sequences. These concern tRNAs and rRNAs and display secondary
structures important for the functionality of these gene products.erican Journal of Human Genetics 84, 628–640, May 15, 2009 629
The software allows users to locate polymorphisms inside stem
and loop regions in tRNAs and rRNAs. The numbering used for
identiﬁcation of each tRNA region was taken from the database
Mamit-tRNA,17 whereas for 12sRNA (MT-RNR1 [MIM *561000])
and 16sRNA (MT-RNR2 [MIM *561010]) it was inferred from the
secondary structures displayed on Mitomaster.
The interface displays a table and a bar graph with the summary
information about diversity, but in order to facilitate further anal-
yses intended by users, some versatile output ﬁles can be saved:
summary accounts of general diversity, information organized
by position, and information organized by sample.
Sequence Accession
The complete or coding-region mtDNA sequences published in
GenBankamountedby the endofAugust 2008 to 5140 individuals,
after curating the database. In fact, the query ‘‘Homo[Organism]
AND gene_in_mitochondrion[PROP] AND 14000:19000[SLEN]
NOTpseudogene[All Fields]’’ returns 5147 sequences, butwe found
that there is some redundancy in the sequences returned and not
onlyHomo sapiens sapiens sequenceswere returned from this query.
We then removed the following sequences from the initial data set:
NC_011137 and AM948965, which refer to the recently published
Neanderthal complete mtDNA sequence;18 J01415, V00662, and
AB055387, which refer to the original Cambridge Reference
Sequence,19 the latter replaced by the one published by Andrews
et al.15 and identiﬁed as AC_000021; X62996, which is an inferred
consensus sequence;20 and NC_001807, used as one of the human
references in RefSeq database, because it is the same sequence as
AF347015.8
For an easy and fast download of sequences in FASTA format we
used the program Geneious in subsets of sequences. These subsets
of sequences are the most advisable format for their subsequent
alignment in BioEdit21 versus the revised CRS,8 via the Clustal
W algorithm. The Clustal W algorithm takes considerable time
for the alignment of sets of 100 sequences andwould be unfeasible
for a simultaneous alignment of the total database, which is also
unnecessary. The automatic alignment was manually checked, in
order to ensure consistency in the inclusion of deletions and inser-
tions at the end of strings of bases (the poly-Cs and poly-CAs
stretches). The rCRS contains an artiﬁcial value N at position
3107 in order to maintain the standard numbering system for
humanmitochondrial sequences, which is widely used in medical
applications. Because all analyzed sequences are aligned against
the rCRS, all of the variations are reported in the standard
numbering system based on the rCRS. Note that although the
mtDNA-GeneSyn program requires equal length sequences, this
requirement is automatically satisﬁed if the sequences analyzed
have been aligned previous to their analysis by mtDNA-GeneSyn,
which should always be the case.
Results
The Current Human mtDNA Database
A complete set of the current human mitochondrial
genomes available in GenBank was assembled as described
in the Material and Methods section. Most of the
sequences deposited in GenBank have information con-
cerning the haplogroup and the geographic origin or
ethnicity of the subject. When that was not the case, this
information was retrieved from the publication or the hap-
logroup classiﬁcation was inferred by using Mitomaster.10630 The American Journal of Human Genetics 84, 628–640, May 15Some haplogroup classiﬁcations were updated in more
recent works, namely most GenBank L sequences were
updated22—and in these cases the updated classiﬁcation
was recorded. All this information for each sequence is
presented in Table S1 available online.
The compilation of all this information allows the
construction of a general informed picture of the present
complete or coding-region human mtDNA sequences
deposited in GenBank. Most of these sequences were
obtained in population genetic surveys performed in
worldwide populations. Screenings performed with clin-
ical purposes accounted for 1228 sequences, correspond-
ing to 23.9% of the database, ranging from centenarians,
LHON (MIM #535000), diabetes, obesity, male infertile
phenotypes, and CADASIL (MIM #125310) to atypical
psychosis. Most of the sequences were complete, with
only 944 (18.4%) missing the control region information.
The geographical origin of these samples, in a broad
sense, covers quite well the world (Figure 1), correcting
the initial predominance of Eurasian sequences23,24 in
mtDNA studies. Concerning the haplogroup afﬁliation,
some caution is advised in accepting the haplogroup clas-
siﬁcations provided by the references and recorded in
Table S1. This is mainly a concern if the sequence is from
an old publication and if a ﬁne subhaplogroup classiﬁca-
tion is intended. Nonetheless, the classiﬁcation presented
can give at least a general idea of how many sequences
were included for the various haplogroups (Table 1). West
Eurasian and East Eurasian haplogroups contributed to
42% and 38%, respectively, of the database, whereas
African haplogroups (including the sub-Saharan L, the
East African M1, and the North African U6) made up
18% of the sequences. Leading the list of most screened
is the West Eurasian haplogroup H, which is by far the
most frequent European mtDNA haplogroup, attaining
frequencies of ~40%–50% in most European populations
and ~20% in Near Eastern populations,25 followed by the
East Eurasian haplogroups D and M(xM*,M1).
Classifying mtDNA Diversity
We estimated the general diversity present in the 5140
human mtDNA sequences for the different genetic regions
of the molecule: the protein-coding genes; the control
region and a few other noncoding positions scattered
throughout the coding region; and the genes with func-
tionally important secondary structures as tRNAs and
rRNAs. In order to quantitatively evaluate this broad diver-
sity, we evaluated both the set of all polymorphic sites and
the subset of all polymorphisms attaining a threshold of
0.1% frequency in the database, corresponding to at least
ﬁve hits. Arguably, this threshold avoids most biases result-
ing from sequencing errors, which potentially are stron-
gest for positions observed in single or very few sequences.
As a comparison for the actually observed polymorphisms,
another data set was formed including all possible substitu-
tions that can hit each position. This can be easily done by
constructing artiﬁcial DNA sequences. For instance, to, 2009
Figure 1. The Geographical Origin of
the 5140 mtDNA Sequences Deposited
in GenBank, as of the End of August
2008
African-American descendants were
included in sub-Saharan Africa and Euro-
pean-American descendants were included
in Eurasians given that they were homo-
geneous groups, bearing haplogroups
belonging to these regions, whereas USA
‘‘Hispanics’’ constituted a mixed sample,
with most lineages belonging to East Asian
haplogroups observed in Native Americans.estimate all possible transitions A to G, we can transform
all As present in the reference sequence to Gs. The same
can be done individually for all remaining transitions (G
to A; C to T; and T to C) and for all transversions (A to C;
A to T; C to A; C to G; G to C; G to T; T to A; and T to
G). These artiﬁcial mtDNA sequences can then be analyzed
in the mtDNA-GeneSyn tool in the same way as the real
sequences. All the raw data are provided in Tables S2–S4.
Variations in Protein-Coding Genes
When considering only substitutions, 4,062 out of 11,395
nucleotide positions (36%) located in protein-coding
regions (double counting the small number of substitu-
tions that were found in regions where two genes overlap-
ped) were polymorphic in this sequence database. These
polymorphic positions were fairly evenly distributed
through the 13 genes (linear squared regression value of
0.892; Figure 2A), although the distribution of observed
polymorphic positions was statistically different from the
distribution of total protein sizes (c2 ¼ 100.204; p <
0.001). For each gene, the amount of polymorphic sites
was 29% in MT-ND3 (MIM *516002) and MT-ND4L (MIM
*516004); 30% in MT-CO1 (MIM *516030) and MT-ND4
(MIM *516003); 33% in MT-ND2 (MIM *516001); 34% in
MT-CO2 (MIM *516040) and MT-ND5 (MIM *516005);
35% in MT-CO3 (MIM *516050); 37% in MT-ND1 (MIM
*516000); 38% in MT-ND6 (MIM *516006); 43% in
MT-CYB (MIM *516020); 54% in MT-ATP6 (MIM
*516060); and 57% in MT-ATP8 (MIM *516070).
A proportion of 63% of these 4062 polymorphic sites
were located on third codon positions, followed by 24%
in ﬁrst codon positions and only 13% in second codon
positions. This led to 1366 nonsynonymous versus 2696
synonymous substitutions (ratio of 1:1.97). Most of the
polymorphic codons coded for neutral apolar amino acids
(66.3%), with 98.5% of those synonymous; followed by
neutral polar-coding codons (25.6%); and only 5% and
3% of the observed polymorphic codons were basic polar
and acid polar-coding codons, respectively (Figure 2B).The AmConsidering only the subset of polymorphisms with
a frequency of at least 0.1%, a total of 1,465 substitutions
were observed out of the 11,395 nucleotide positions
located in protein-coding regions, corresponding to 13%
of all sites. This result conﬁrms the high level of mtDNA
diversity that occurs at very low frequencies (below this
threshold) in the worldwide human population. These
polymorphic positions were also evenly distributed
through the 13 protein-coding genes (linear squared
regression value of 0.872; c2 ¼ 49.411; p < 0.001; the set
of ﬁgures for polymorphisms with a frequency of at least
0.1% is given in Supplemental Data), ranging from 10%
to 21% with 10% in MT-CO1, MT-ND3, and MT-ND4L;
11% in MT-CO3; 12% in MT-ND4 and MT-ND5; 13% in
MT-CO2 and MT-ND6; 14% in MT-ND2; 15% in MT-ND1;
16% in MT-CYB; 18% in MT-ATP6; and 21% in MT-ATP8.
The proportions between the ﬁrst, second, and third codon
positions were, respectively, 23%, 9%, and 68%, yielding
397 nonsynonymous versus 1068 synonymous substitu-
tions (a ratio of 1:2.69). The pattern for polymorphisms
in amino acids of different physical properties also fol-
lowed the general observations in the full set of polymor-
phisms as described above.
A total of 88% of the complete list of polymorphic posi-
tions were transitions, yielding a transversion:transition
ratio of 1:7.5, when not accounting for redundancy in
the human phylogeny. The dominance of transitions in
the evolution of animal mtDNA (not just human mtDNA)
has long been recognized.26 This transversion:transition
ratio increased to 1:21.2 when considering only the poly-
morphisms over the 0.1% threshold in the population
(95% transitions to 5% transversions), further empha-
sizing the rarity of transversions. The proportion of transi-
tions was higher in the set of polymorphisms with preva-
lence >0.1% of the population than in the complete data
set, so thismay indicate that there is more selection against
the transversion mutations.
We compared the set of all observed transitions in the
protein-coding genes to all possible transitions from theerican Journal of Human Genetics 84, 628–640, May 15, 2009 631
Table 1. Haplogroup Affiliation of the 5140 mtDNA
Sequences Deposited in GenBank by the End of August 2008
Population n
West Eurasian
pre-HV or R0a 31
H 781
HV 83
I 50
J 170
K 237
N1 35
other R 94
T 169
U* þ U1-3 73
U4 75
U5 156
U7-9 27
V þ pre-V 87
W 69
Total 2137
East Eurasian
A 257
B 246
C 138
D 507
E 54
F 71
G 100
other M 391
N9 69
other N 10
O 1
P 31
Q 28
S 13
Y 13
Z 31
Total 1960
Pan Eurasian
X 60
Total 60
Unclear (Eurasian?) n
M* 55
N* 8
Total 63
African
L0 142
L1 140
L2 210
L3 270
other L 42
M1 68
U6 48
Total 920
The classification of haplogroups in large population groups followed Mac-
aulay’s phylogenetic tree.632 The American Journal of Human Genetics 84, 628–640, May 15reference sequence. The observed transitions in the
protein-coding region corresponded to 31.5% of the
maximumnumber possible (3,585 out of 11,395), a surpris-
ingly high proportion, with ratios between the four
possible transitions highly correlated (Table 2). When
comparing observed and maximum values for transitions
(Figure 3A) in each of the 13 protein-coding genes,
a good correlation (r2 ¼ 0.896) was obtained with MT-
CO1 having the lowest proportion of observed transitions
compared to all possible ones and MT-ATP6 the largest
proportion. When the transitions were partitioned by the
type of substitution, the lowest correlating type was G to
A (r2 ¼ 0.657; not shown); the other types of transitions
showed good correlations between observed and
maximum values (r2 ¼ 0.895 for A to G; r2 ¼ 0.946 for C
to T; and r2 ¼ 0.819 for T to C). Despite the high correla-
tions, there was a slightly signiﬁcant difference in the
proportions of the four transition types when comparing
the observed transitions to the set of all possible transitions
(Table 2; p ¼ 0.042 by chi-square test).
Out of all of the possible sites within protein-coding
genes where transversions could have occurred, only
2.1% of these sites were observed to have transversions
in this sequence data set (477 in 22790). When the data
were broken down into the different types of transversions
(Table 3), there was a good correlation between the
numbers of observed and the maximum number of trans-
versions. However, there was also a highly signiﬁcant
Figure 2. Protein Diversity
Correlation between the observed polymorphic positions and the
gene size (bp) in the 13 protein-coding genes (A) and distributions
of types of amino acids before and after the substitution (B)., 2009
difference in the proportions of each type of transversion
(c2 ¼ 63.498; p < 0.001), with a considerable excess of C
to A and a weaker excess for G to C transversions, leading
to the proportional reduction of the other categories. That
excess of C to A was shared by all the 13 protein-coding
genes (r2 ¼ 0.829), accounting for the good correlation in
total transversion among those genes (r2 ¼ 0.830;
Figure 3B). Bandelt et al.27 reported a ratio of transversions
of 17 to A, 9 to C, 7 to T, and 3 to G (or 5.7:3:2.3:1), in
a Eurasian mtDNA tree. Here the values are 183 to A, 95
to C, 80 to T, and 119 to G (or 1.5:0.8:0.7:1). These propor-
tions show some deviations from unity, but not as
pronounced as the data of Bandelt et al.27 This difference
could be explained by an excess of transversions to G
resulting from sequencing errors as reported27 to occur in
some published data sets. Those authors report that in
cases of a C following a few Gs, such as in GGC, some
misclassiﬁcations (or what they call phantom mutations)
are reported as GGG. But in the total database, only 13 sites
were mutations from GGC to GGG (of which only 3 sites
are observed to vary at over the threshold 0.1% of the
population).
When the same comparison was made between the
maximum possible values for transitions and transversions
and the observed polymorphisms with frequency of at
least 0.1% in this database (Supplemental Data), the results
were quite similar to those for the full set of observed poly-
morphisms just described. For transversions, there were 34
to A, 10 to C, 12 to T, and 10 to G (or 3.4:1:1.2:1), showing
again that the huge difference between values of transver-
sions to A and to G as observed by Bandelt et al.27 in the
Eurasian data set is not so strong in this larger worldwide
data set.
The observed diversity in terms of synonymous and
nonsynonymous substitutions was of 32.5% (2,696 out
of 8,291 possible) and 5.3% (1,366 out of 25,894 possible),
respectively, compared to all possible substitutions in the
protein-coding genes. When the analysis was broken
down by each of the 13 protein-coding genes, an
extremely high correlation was obtained for synonymous
substitutions (r2 ¼ 0.989) but not for nonsynonymous
substitutions (r2 ¼ 0.412), with higher observed nonsy-
nonymous substitutions for MT-ATP6 and MT-ATP8
and lower for MT-CO1, MT-ND4, and MT-ND5 (Figure 4).
Identical patterns were observed for the smaller subset of
Table 2. Maximum Numbers and Observed Values for
Transitions in the 13 Coding-Protein Genes
Type
Maximum
Number (%)
All Observeda
(%)
Observedb in >0.1%
of Population (%)
G-A 1339 (11.8) 412 (11.5) 250 (17.9)
A-G 3386 (29.7) 1154 (32.2) 417 (29.8)
C-T 3785 (33.2) 1158 (32.3) 306 (21.9)
T-C 2885 (25.3) 861 (24.0) 426 (30.4)
a Compared to the maximum number c2 ¼ 8.206; p ¼ 0.042.
b Compared to the maximum number c2 ¼ 100.393; p < 0.001.The Ampolymorphisms with frequencies of 0.1% or more of the
population.
To understand the nonsynonymous substitutions, we
broke them down into the individual amino acid changes
and compared this to the total number of changes to each
amino acid that were possible by making all single nucleo-
tide replacements from the reference sequence (Figure 5).
This analysis gave us the ﬁrst result that was not either
random or a simple linear relationship between the actual
changes and the maximum number of changes. Instead,
a group of amino acids (V, A, and T) clearly show a different
behavior than the other amino acids. The observed varia-
tions to the other amino acids showed a relatively linear
relationship to the total possible number of alterations,
indicating that these variations are occurring in the
human population at roughly an equal rate. In contrast,
the V, A, and T group lie farther to the right in the plot,
meaning that a higher proportion of all possible changes
to these three amino acids is present in the human popu-
lation. The vast majority of all variations found in the
human mtDNA are transitions, so we considered the sets
of amino acids with codons that can be interconverted
by single transitions via the vertebrate mitochondrial
genetic code. This separates the amino acids into only
four groups: (V, I, A, M, T), (L, P, F, S(UCN)), (H, Y, C, R,
Q, W, stop(UAA/G), and (N, D, G, S(AGU/C), E, K, sto-
p(AGA/G)). Interestingly, in the two larger groups almost
all transitions cause a change in the chemical properties
Figure 3. Transitions and Transversions
Correlation between the observed and maximum possible varia-
tions for (A) transitions and (B) transversions in the 13 protein-
coding genes.erican Journal of Human Genetics 84, 628–640, May 15, 2009 633
(acid-neutral-base or polar-apolar) of the amino acid. In
the two smaller groups, all but one of the amino acids in
each group has the same properties, neutral apolar. These
two groups also are the amino acid variations most often
observed in the human population, with the (V, I, A, M,
T) group occurring at the highest rate (Figure 5). This is
also visible in the analysis of the amino acid chemical
properties in Figure 2B, where most of the observed
changes are between neutral apolar amino acids.
Potentially themost severe nonsynonymous pointmuta-
tions are those occurring in stop codons. In this database of
humanmtDNA sequences, nine substitutions affected stop
codons.Of these, ﬁve continue tomean stop,whereas,most
interestingly, theother four increase theprotein size. Twoof
these occur inMT-CO1, converting the stop codon to abasic
polar amino acid, extending the open-reading frame
by three codons into the adjacent tRNA-Ser (UCN) gene
(MT-TS1 [MIM *590080]), and thus extending the corre-
sponding protein by three amino acids. One of these varia-
tions is located at position 7444 and has been associated
with LHON disease28 (MIM #535000) but is seen in many
population samples from different haplogroup back-
grounds and has been reported in diverse publications
(the 27 samples bearing it in the database are distributed
by haplogroups A2, H, H3, HV, D4, D4e1, L2a, L1b, L1b1a,
L3e, L3f1b2, M7a, M38, and V with accession numbers
DQ282408, EF657747, EF657594, AM260606, AM260607,
AM260608, AM260609, AM260610, AM260611,
AM260612, AP009431, AP010714, EF184618, EF184619,
DQ112737, EU092893, DQ282507, EU092805, AP010747,
AY922286, DQ112936, AF347006, AY339446, AY339447,
AY339448, AY339449, and AY339450). The other variable
site at position 7445C was seen in patients with hearing
loss but was concluded by those authors to be insufﬁcient
to cause the phenotype29 (in the database it was observed
in one individual belonging to haplogroup D6, accession
number EU482325). Another substitution at position
9205 converts the stop codon to a neutral polar amino
acid, extending the ATP6 protein by 10 more amino acids
coded from the adjacent MT-CO3 gene (Q-W-P-T-N-H-M-
P-I-M) and was observed in two individuals with hap-
Table 3. Maximum Numbers and Observed Values for
Transversions in the 13 Coding-Protein Genes
Type
Maximum
Number (%)
All Observeda
(%)
Observedb in >0.1%
of Population (%)
A-C 3386 (14.9) 60 (12.6) 5 (7.6)
A-T 3386 (14.9) 66 (13.8) 9 (13.6)
C-A 3785 (16.6) 140 (29.4) 27 (40.9)
C-G 3785 (16.6) 67 (14.0) 7 (10.6)
G-C 1339 (5.9) 35 (7.3) 5 (7.6)
G-T 1339 (5.9) 14 (2.9) 3 (4.5)
T-A 2885 (12.7) 43 (9.0) 7 (10.6)
T-G 2885 (12.7) 52 (10.9) 3 (4.5)
a Compared to the maximum number c2 ¼ 63.498; p < 0.001.
b Compared to the maximum number c2 ¼ 31.318; p < 0.001.634 The American Journal of Human Genetics 84, 628–640, May 15logroupsX2* andA2, from twodifferent data sets (accession
numbers EU600328 and EU431081). Notice that although
this site is listed in Mitomap as polymorphic, the reference
indicated seems tobewrong.The explanation for a termina-
tion codon being found in theMT-CO3 gene is that the ﬁrst
position of theMT-CO3 ﬁrst codon corresponds to the third
position of the MT-ATP6 termination codon, generating
a reading-frame shift. And ﬁnally, the variation at 10765T
converts a stop codon to a neutral apolar amino acid,
extending the ND4L protein by two more amino acids
(L-N) coded from the overlapping MT-ND4 gene, which is
naturally in a reading-frame shift relative to ND4L. This
substitution was observed in one L0k individual (accession
number EF184609).
The opposite effect, amino acid coding codons convert-
ing to a stop codon, was observed in ﬁve cases: three
involving amino acid W at positions 4720 and 5185 in
MT-ND2 (the 84th and 239th amino acids, respectively,
in a total of 347 amino acids; accession numbers
EF661000 and EF660972, respectively), and at position
11403 in MT-ND4 (the 215th amino acid of a 459 amino
acid protein; accession number EF661005), all occurring
in patients with thyroid cancer. Another involved amino
acid M at position 10657G, which has been detected in
two patients with thyroid cancer (accession numbers
EF660984 and EF660998), occurring at position 63 in
Figure 4. Synonymous and Nonsynonymous Sequence
Changes
Correlation between observed and maximum possible variations
for (A) synonymous and (B) nonsynonymous substitutions in the
13 protein-coding genes., 2009
MT-ND4L, which has 98 amino acids. The last one
involved a K amino acid at position 15606 in MT-CYB
(the 287th amino acid of a total of 380), occurring in one
individual with thyroid cancer (EF660990). So, whereas
extension of a protein by a few amino acids can be seen
in the neutral population, the shortening of proteins was
observed only in pathological cases.
Variations in the Control Region and Noncoding Sites
inside the Coding Region
A total of 692 polymorphisms were observed in the control
region, dispersed throughout 560 positions out of the
1123 bp total length. Several positions had three alleles
(92 positions) and even four alleles (20 positions). Of these
total polymorphisms, 513 were transitions and 179 trans-
versions, leading to a ratio of 1:2.9, not accounting for
redundancy. With the threshold of 0.1% frequency, these
values were 326 polymorphisms observed throughout
295 positions, being 284 transitions and 42 transversions
(ratio of 1:6.8). Again the pattern holds that the transition
to transversion ratio increases when only the higher-
frequency variations are considered.
For the D loop, the frequency of observed transitions
and transversions, relative to possible values, were 45.7%
(513 of 1122) and 8% (179 of 2244), respectively, testifying
the higher mutation rate of this region relative to the
protein-coding region, even not accounting for recurrence.
The correlation between the observed and maximum
possible numbers of different types of substitutions and
different types of transversions were very high (r2 ¼
0.976 and r2¼ 0.768, respectively), indicating no tendency
for certain types of substitutions inside each class.
There are some positions along the coding region that
are noncoding, summing up to a total of 89 positions. In
these positions, 50 polymorphisms were observed, distrib-
uted along 43 positions (7 had three alleles, and curiously,
6 were transversions to C and just 1 to A). One important
region located in these positions is the assumed L-strand
Figure 5. Correlation between Observed and Maximum
Possible Variations for Amino Acids Originated from Nonsynon-
ymous Mutations
The amino acids from group (VIAMT) are represented by red squares
and the ones from group (FLPS) are represented by blue circles; the
remaining amino acids are represented by black diamonds.The Amorigin of replication (OL), which is located between posi-
tions 5721 and 5798, overlapping in the ﬁrst 9 bases
with tRNA-Asp (MT-TD [MIM *590015]) and in the last
38 bases with tRNA-Cys (MT-TC [MIM *590020]). In the
nonoverlapping stretch of the OL, ﬁve polymorphisms
were observed, all closely located in the middle of this
region, which can be important for inferences about the
functionality and structure of OL. In fact, compared to
a secondary structure calculated by the mfold program,30
all those polymorphic positions are located inside a single
predicted loop (Figure 6).
tRNAs and rRNAs
Many of the conﬁrmedmtDNA pathological mutations are
located on tRNAs, especially on the stem portions.31 Given
that the sizes of the various tRNAs are quite similar, varying
only from 65 to 75 bp, there were some interesting differ-
ences in variability between the tRNA genes. The genes for
the tRNAs Met, Tyr, and Asn (MT-TM [MIM *590065],
MT-TY [MIM *590100], and MT-TN [MIM *590010])
showed the fewest polymorphisms (less than 10), whereas
all the other tRNAs showed between 11 and 24 polymor-
phisms, except threonine (MT-TT [MIM *590090]), which
displayed a double level of polymorphisms, 41 (Figure 7).
This renders the relation between observed polymor-
phisms and size totally uneven (linear squared regression
value of 0.08; not shown). The same result occurs when
only analyzing those polymorphisms present at a
frequency of 0.1% or higher (linear squared regression
value of 0.10; data not shown).
This highest amount of polymorphisms observed in
MT-TTwas previously identiﬁed in a worldwide phylogeny
based on 277 sequences published.32 The increase in
MT-TT diversity occurs mainly in the stem region, which
contains almost double the number of polymorphisms
than were found in the loops. As can be seen in Figure 8,
some polymorphisms in the human population are located
in positions identiﬁed as 100% and >90% conserved in
mammalian tRNAs.32
Other tRNA genes also have higher numbers of varia-
tions in the stems than in the loops: alanine (MT-TA
[MIM *590000]), arginine (MT-TR [MIM *590005]),
cysteine (MT-TC), glutamine (MT-TQ [MIM *590030]),
Figure 6. Distribution of Polymorphic Positions in the Various
Structural Regions of the tRNA Geneserican Journal of Human Genetics 84, 628–640, May 15, 2009 635
glycine (MT-TG [MIM *590035]), leucine UUR (MT-TL1
[MIM *590050]), proline (MT-TP [MIM *590075]), serine
AGY (MT-TS2 [MIM *590085]), and serine UCN (MT-TS1).
The tyrosine and valine tRNA genes (MT-TY and MT-TV
[MIM *590105]) have the same number of polymorphisms
in the stems and loops. Another interesting point is that
tRNA-Met (MT-TM) has no polymorphisms in stems (ﬁve
are located in loops and one is located in other positions),
which is consistent with the main function of this tRNA as
the initiator of all mtDNA proteins. In total over all tRNA
genes, the amount of mutations in stem regions (148)
was similar to the amount in the loop regions (150),
which seems in contradiction to the functional constraint,
but this, again, was estimated without taking into
consideration the redundancy of substitutions and the
Figure 7. Variability in the Region of the Origin of the Light
Strand Related to the Inferred DNA Secondary Structure
Secondary structure of the OL region inferred in mfold28 with the
observed polymorphic positions 5741, 5742, 5744, 5746, and
5747 indicated.636 The American Journal of Human Genetics 84, 628–640, May 15larger proportion of each tRNA gene contained in the
stems.
But if these observed values are compared with the
maximum possible values, the functional constraint does
seem to play an important role in driving tRNA diversity.
In fact, when analyzing the locations of all possible substi-
tutions, the total number in stem regions is 2670; for loop
regions it is 1332; and for variable regions and other sites
519. In this way, we would expect a ratio of stem:loop of
2 but the observed ratio was 0.99, not accounting for
redundancy. The lower variation in the stem regions is
consistent with expectations that such regions should be
more constrained by selection (in order to maintain the
tRNA and rRNA secondary structure) and has been re-
ported recently on an analysis of 2460 human mtDNA
sequences.33 The maximum possible values were very
similar for all tRNAs, so the high excess of substitutions
observed in tRNA-Thr (MT-TT) indicates that the vari-
ability in this gene is much higher thanmight be expected,
especially in the stem regions (Figure 6).
Figure 8. Variability in a tRNA Gene Related to the RNA
Secondary Structure
The secondary structure of the threonine tRNA and the observed
polymorphic positions in the human database (gray hexagons),
and positions that are 100% (square) and>90% (circle) conserved
in mammalian species.30, 2009
There is the possibility that some of those stem polymor-
phisms could be compensating base changes, where one
substitution in one side of the stem that would lead to
a less stable stem is corrected by a substitution at the
same position in the other side of the stem, stabilizing
the tRNA secondary structure. This was observed to occur
in the primate lineage in one large secondary structure
located in the control region.34 Of course, there is the ques-
tion whether the time since the emergence of the modern
human species (~200,000 years ago) is enough for these
compensating polymorphisms to have occurred.We evalu-
ated this by checking the placement of the detected tRNA
polymorphisms against the tRNA secondary structure
(Supplemental Data). Of the 34 pairs of polymorphisms
that colocate at the same position in both sides of the
tRNA stems, only one pair (7528 and 7538G) was observed
in the same individual belonging to haplogroup M21
(accession number DQ834257) but causing a mispairing
between G-G. So compensating polymorphisms in the
tRNA stem structures does not appear as an important
feature in the human mtDNA diversity.
Very curiously, there were a few instances of polymor-
phisms affecting the anticodon of four tRNAs. The varia-
tion at site 12170 in the tRNA histidine gene transforms
the anticodon GTG in GTA, observed in an individual
from haplogroup A2 (accession number EU007838). The
polymorphism 12300T transforms TAG to TAT in MT-TL2
(MIM *590055) in an L3 individual (accession number
EF184640). The variation at site 8324 transforms TTT to
TCT in MT-TK (MIM *590060) in an R5a2b2 individual
(accession number FJ008429). And ﬁnally, the polymor-
phism at position 1633 atMT-TV transforms the anticodon
TAC to CAC in an individual from haplogroup N2 (acces-
sion number EU787451). All these tRNAs are coded in
the H-strand, so the above substitutions at the third posi-
tion correspond to the ﬁrst position in the codon, and
vice versa, so that the one occurring in MT-TH (MIM
*590040) would change the amino acid association to
Tyr; the substitution inMT-TL2 would change the associa-
tion from CUN to UUR, remaining a leucine; the substitu-
tion inMT-TK would convert to an association with a stop
codon; and the substitution in MT-TV would be synony-
mous. These substitutions leading to different functions
for the altered tRNAs give ample reason to suspect that
these variations are incorrect.
Of the 22 tRNA substitutions displayed on Mitomap
(edition 28 July 2008) as having a conﬁrmed pathological
effect, only 4 were observed in our database: the MT-TL1
variation A3243G, only present in patients from diverse
diseases (2 MELAS [MIM #540000], 1 OXPHOS deﬁciency,
and 1 thyroid cancer; respective accession numbers
DQ862536, DQ826448, DQ489509, and EF661012); the
MT-TS1 variation G7497A, present in one patient with
OXPHOS deﬁciency (accession number DQ489514); the
MT-TK variation A8344G, observed in one MERRF (MIM
#545000) patient (accession number DQ862537) and in
one individual from haplogroup V in the population studyThe Amof Mishmar et al.35 (accession number AY195750); and the
MT-TE (MIM *590025) variation T14709C, described in the
population survey of Herrnstadt et al.,24 belonging to hap-
logroup T1 (accession number EF657686). Many of the
tRNA substitutions listed on Mitomap as ‘‘reported’’ or
‘‘unclear’’ were observed in the GenBank database, some
in considerable frequency. This frequency information is
important for ascertaining the potential pathological effect
of these variations (Table S5).
The rRNA genes presented a higher proportion of poly-
morphisms on loop regions than on stem regions: 72.6%
and 27.4%, respectively, for the 12 s rRNA gene MT-RNR1;
and 85.6% and 14.4%, respectively, for the 16 s rRNA
gene MT-RNR2 (using the rRNA secondary structure calcu-
lated frommfold). The comparison with all possible substi-
tutions also testiﬁes to the prevalence of substitutions in
loop regions. For MT-RNR1, the observed and expected
ratios between stem:nonstem regions were 0.78 and 0.38,
respectively. For MT-RNR2, these values were 0.63 and
0.17, respectively. In both rRNA genes, variations were dis-
proportionally present in the predicted loop structures, as
one would expect.
Discussion
The mtDNA-GeneSyn tool allows an easy and fast identiﬁ-
cation and measurement of the diversity present in large
data sets of complete mtDNA genomes. Users have total
freedom in analyzing any desired data set. Furthermore,
the description and characterization of the current
complete human mtDNA genomes deposited in GenBank
performed here, and its availability to readers as Supple-
mental Tables, allows the easy construction of many
desired databases, such as a neutral population data set
from East Asia, thyroid cancer data, or African L2 hap-
logroup data. The GeneSyn tool allows the investigator
to use up-to-date groups of mtDNA sequences instead of
relying on a static database, such as mtDB that has
remained at 2704 complete sequences for several years
now. The GeneSyn tool is not a web resource and can be
downloaded and used locally, so there is no issue with
conﬁdentiality of the gene sequences being analyzed, as
there is with MitoMaster, which retains all sequences
submitted for analysis.
Based on our survey, it is clear that the largest amount of
sequences currently deposited in GenBank resulted from
population studies. Although this bias can be partially
explained by clinical studies still being mainly performed
in segments of the mtDNA molecule instead of typing
the complete genome, there are clearly many authors
from the clinical ﬁeld who are not submitting sequences
to GenBank. The centralized role of GenBank as the
main repertoire of human diversity and its utility for
researchers must then be reinforced.
The characterization of the diversity present in 5140
complete or coding-region human genomes and itserican Journal of Human Genetics 84, 628–640, May 15, 2009 637
comparison with the maximum possible diversity for
human mtDNA can serve as references for case studies
and for comparative species evolution. This comparison
showed clearly that mutation restrictions related with
secondary structure conformation are the main cause for
an uneven distribution of mtDNA diversity. These restric-
tions are strong in tRNAs and rRNAs, genes for which
the secondary structure is essential for functionality, but
also in regions related with regulation, as the OL. On the
other hand, for protein-coding genes, the most obvious
feature was the bias against mutation at the second codon
position.
Despite the clear and reasonable bias against nonsynon-
ymous variations in the protein coding genes, our analysis
indicates that a certain subset of these variations are better
tolerated, and therefore are observed at both a higher abso-
lute rate and a higher rate relative to the total number of
possible variations to these amino acids (Figure 5). The
tolerated variations are among the group of amino acids
V, I, A, M, and T, which can be interconverted by transi-
tions and which all but one (T) are neutral apolar amino
acids. Curiously, although T is the only polar amino acid
in this group, it is also the amino acid change (compared
to the reference sequence) that is most often observed in
the human sequence data (Figure 5). A detailed discussion
of the physical and chemical properties of the amino acids
changes observed in a set of 840 human sequences is given
by Moilanen and Majamaa.36
This study provides a complete listing of the current
knowledge of mtDNA variation in the human population,
available as Table S2. This list can be consulted by investi-
gators faced with assessing the importance of a particular
sequence variation, which may be found, for example, in
a clinical investigation. The analysis also indicates that
some nonsynonymous alterations in protein-coding genes
(within the V, I, A, M, and T group) have been more easily
tolerated in human evolution, and thus may be less likely
to be pathogenic alterations in a patient. Perhaps most
importantly, this study provides the tools so that this
knowledge can be updated by the individual investigator
as the number of sequences available grows, as it is certain
to do in the near future. These tools and the methods out-
lined in this paper can also be used by investigators with
their own sequence database, either gathered from a partic-
ular geographic area or as part of a case-control phenotype
study.
The two resources provided in this paper (the current
mtDNA variation list and the computational tools for
creating such a list from sequence data sets supplied by
the user) will be useful for many studies. For example,
Stewart et al.37 recently reported exciting new results on
selection of mtDNA variants after following heteroplasmic
mice through several generations. In that paper they were
limited in their comparison of their mouse model to the
human mtDNA variation database mtDB, which we dis-
cussed in the introduction, instead of utilizing the much
larger full data set of human mtDNA variation that was638 The American Journal of Human Genetics 84, 628–640, May 15available in GenBank at that time. The information and
tools presented here should remove these limitations
from future studies. Another example of a large-scale study
that could be based on this data would be to model
the effects of the observed amino acid changes on the
protein structure and function, in order to look for
selection effects there (potentially related to the results of
Stewart et al.37), and also to explain the distribution of
observed human variation in terms of the affected protein
domains.
Supplemental Data
Supplemental Data include six ﬁgures and ﬁve tables and can be
found with this article online at http://www.ajhg.org/.
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